DiagnaMed Announces LIFE Offering of up to $510,000

Core Points - DiagnaMed Holdings Corp. is arranging a private placement of units with a minimum of $350,000 and a maximum of$510,000 at a price of $0.03 per unit [1][2] - Each unit consists of one common share and one common share purchase warrant, allowing the holder to acquire an additional common share at$0.05 for 24 months [2] - The net proceeds from the offering will be used for research, development, and commercialization of hydrogen production technology and the BRAIN AGE® Brain Health AI Platform [4] Offering Details - The offering may include finder's fees of up to 8% of gross proceeds and non-transferable finder warrants [5] - Up to 17,000,000 units may be issued under the Listed Issuer Financing Exemption, with no resale restrictions [6] - The anticipated closing date for the offering is on or about March 31, 2025, subject to regulatory approvals [7] Company Overview - DiagnaMed Holdings Corp. focuses on innovative technology solutions in the cleantech and life sciences sectors, particularly in hydrogen production and AI-driven drug discovery [8]